-
Oct 17, 2024
In August, federal officials announced the final prices of 10 drugs that they previously selected for the Medicare Drug Price Negotiation program.
That program, which was created by...
-
Jul 16, 2024
The history of tofacitinib (Xeljanz) is an example of an innovative treatment that could now be stifled under new Medicare drug pricing rules.
-
Jul 15, 2024
The history of tofacitinib (Xeljanz) is an example of an innovative treatment that could now be stifled under new Medicare drug pricing rules.
Oct 17, 2024In August, federal officials announced the final prices of 10 drugs that they previously selected for the Medicare Drug Price Negotiation program. That program, which was created by...
Jul 16, 2024The history of tofacitinib (Xeljanz) is an example of an innovative treatment that could now be stifled under new Medicare drug pricing rules.